Gefapixant citrate, is a prescription medication used to treat adults with refractory or unexplained chronic cough. It is a non-narcotic option for a persistent cough (lasting 8 weeks or longer) that has not responded to conventional treatments or for which no underlying cause can be found. It is grouped under the following drug class(es): Antitussives. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Lyfnua. Its PubChem CID is 145720531.
Gefapixant citrate
| CAS No | 2310299-91-1 |
|---|---|
| Molecular Formula | C20H27N5O11S |
| Molecular Weight | 545.5 g/mol |
| Synonyms | 5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide;2-hydroxypropane-1,2,3-tricarboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Gefapixant citrate, is a prescription medication used to treat adults with refractory or unexplained chronic cough. It is a non-narcotic option for a persistent cough (lasting 8 weeks or longer) that has not responded to conventional treatments or for which no underlying cause can be found.
The listed CAS number is 2310299-91-1.
The listed molecular formula is C20H27N5O11S.
The listed molecular weight is 545.5 g/mol.
5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide;2-hydroxypropane-1,2,3-tricarboxylic acid.
The source lists Lyfnua.